ETFs › IBB

iShares Biotechnology ETF (IBB)

biotechnology healthcare growth-potential

The iShares Biotechnology ETF offers exposure to the dynamic biotechnology sector. This fund provides investors with a way to tap into the potential of innovative companies working on groundbreaking medical treatments and technologies. It's an excellent choice for those looking to add growth potential to their portfolio while supporting advancements in healthcare.

Key Info

AUM $7.56B
Expense Ratio 0.45%
Inception Date February 5, 2001
Distribution Frequency Quarterly
Weighting Method Market Cap
Number of Holdings 268
Tracking Index ICE Biotechnology Index

See Also

XBI IBB XLV

Last updated: September 5, 2024